Embecta Corp. provided earnings guidance for the fiscal year 2024. For the year, the company expects revenues to be $1,111 million -$1,116 million against previous guidance of $1,094 million- $1,116 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.12 USD | -2.25% | 0.00% | -25.09% |
16/05 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
09/05 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.09% | 83Cr | |
-5.96% | 18TCr | |
+3.00% | 11TCr | |
-3.14% | 6.83TCr | |
+5.34% | 5.22TCr | |
+7.68% | 4.43TCr | |
+6.67% | 4.27TCr | |
+25.62% | 3.25TCr | |
+20.03% | 2.6TCr | |
-1.35% | 2.59TCr |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024